News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Capital return
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
AQR Capital Management, along with its affiliates, has reported a beneficial ownership of 658,138 Ordinary Shares in Veraxa Biotech Holding AG, which includes warrants. This position represents 0.46% of Veraxa’s outstanding Ordinary Shares, confirming that the AQR group holds less than the 5% threshold. …
5 Insightful Analyst Questions From Equitable Holdings's Q2 Earnings Call Equitable Holdings' second quarter was marked by strong adjusted earnings growth, resilient net flows across its core segments, and notable progress on its pending merger with Corebridge. While the company's sales declined year over …
Barrow Hanley Global Investors has disclosed an 8.2% beneficial ownership stake in Axalta Coating Systems Ltd. (AXTA) through a Schedule 13G filing. This amounts to 17,505,233 shares, with the firm holding sole voting power over 11,865,985 shares and shared voting power over 5,639,248 shares. …
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Strategy Officer and Head of Investor Relations - Erik Bass President and Chief Executive Officer - Mark Pearson Chief Financial Officer - Robin Raju President, Equitable Financial …
Pacer Advisors Inc. significantly reduced its stake in Axalta Coating Systems Ltd. (NYSE:AXTA) by 90.2% in the first quarter, now holding 24,561 shares valued at $680,000. Despite this, other institutional investors increased their positions, with institutions collectively owning 98.28% of Axalta's stock. Axalta recently …
Axalta Coating Systems (NYSE:AXTA) has received an average "Hold" rating from analysts, with 11 out of 15 recommending a hold and four recommending a buy. Despite the average 12-month price target of $36.00 being below its opening price of $37.46, the company surpassed quarterly …
This article provides an earnings forecast for Veraxa Biotech AG Ord Shs (VRXA), detailing its future EPS and Revenue Growth Estimates. It includes current stock performance data, market capitalization, and a peer comparison with other biotechnology and medical research companies. The financial forecasting sections …
Equitable Holdings (EQH) reported a Q2 2026 net loss of US$453 million and a revenue decline to US$1,658 million, yet the stock is up 8.1%. The company completed US$366 million in share repurchases, bringing total buybacks to US$2.81 billion under its February 2024 program. …
Investors interested in Chemical - Specialty stocks are likely familiar with Axalta Coating Systems (AXTA) and Hawkins (HWKN). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that …
Axalta Coating Systems (NYSE:AXTA) has reached a new 52-week high of $38.61 despite an average analyst rating of "Hold" and a $36.00 price target. The company exceeded Q2 expectations with $0.72 EPS and $1.35 billion in revenue. Institutional investors hold a substantial 98.28% of …
Shareholders of Axalta Coating Systems Ltd. and Akzo Nobel N.V. have approved their previously announced all-stock merger of equals. This combination aims to create a premier global coatings company with enhanced capabilities and growth potential. The merger is expected to be completed in late …
Veraxa Biotech Holding AG (NASDAQ: VRXA) announced the effectiveness of its F-1 filing with the SEC, dated August 6, 2026, at 4:00 P.M. The filing indicates a neutral impact and sentiment, as analyzed by StockTitan's AI. This notice of effectiveness relates to the company's …
Axalta Coating Systems (NYSE:AXTA) has been downgraded by Wall Street Zen from a "strong-buy" to a "buy" rating, though the broader analyst consensus remains "Hold" with an average price target of $36.00. The company's shares opened at $38.22, near their 12-month high, and have …
Axalta Coating Systems (AXTA) recently reported mixed Q2 2026 results and guidance, showing revenue trends, profit pressures, and expectations for low single-digit net sales growth. Despite a significant 34.5% share price return over 90 days and one year, the company is considered 100% undervalued …
The Manufacturers Life Insurance Company reduced its stake in Axalta Coating Systems Ltd. (NYSE:AXTA) by 28.4% in the first quarter, selling over 40,000 shares but still retaining a significant holding valued at $2.84 million. Despite this decrease and mixed analyst ratings with an average …
VERAXA Biotech is making significant strides in antibody therapeutics with its proprietary BiTAC platform, focusing on bispecific ADCs and T-cell engagers. The company's platform is designed for precision and efficacy, positioning it for potential partnerships and licensing deals in the rapidly growing market for …
Key Points Interested in Equitable Holdings, Inc.? Here are five stocks we like better. Second-quarter operating earnings rose: Equitable reported $488 million in non-GAAP operating earnings, or $1.70 per share, while assets under management and administration reached a record $1.2 trillion. The company returned …
VERAXA Biotech (NASDAQ: VRXA) has advanced its VXA-222 bispecific antibody-drug conjugate (bsADC) program into the next development stage after successfully completing the discovery phase with OmniAb Inc. The company will now focus on engineering the final therapeutic candidate and conducting preclinical validation. VERAXA also …
Axalta Coating Systems (NYSE:AXTA) reported soft earnings, but the company's stock remained strong due to underlying positive indicators. The earnings were negatively impacted by a significant US$95m expense from unusual items, which are typically non-recurring. Analysts believe that if these unusual expenses do not …
Axalta Coating Systems announced strong financial results for Q2 2026, with net sales reaching $1.35 billion, a 3% increase year over year. The company reported record Adjusted EBITDA and Adjusted Diluted EPS, expanded margins, and robust free cash flow generation. CEO Chris Villavarayan highlighted …
Equitable Holdings' stock jumped 6% despite reporting widening GAAP losses in Q2 2026, driven by solid non-GAAP operating earnings and record assets under management. While the bullish case highlights strong operating metrics and capital plans, concerns remain about GAAP volatility, product mix risk, and …
Shareholders of AkzoNobel N.V. and Axalta Coating Systems have overwhelmingly approved their previously announced all-stock merger of equals. Both companies released statements from their CEOs, Chris Villavarayan of Axalta and Greg Poux-Guillaume of AkzoNobel (who will lead the combined entity), expressing excitement about the …
Shareholders of both Axalta Coating Systems Ltd. and Akzo Nobel N.V. have approved their proposed merger of equals, moving closer to combining the two coatings businesses. The merger is still subject to regulatory approvals and other closing conditions, with an expected closing window of …
Axalta Coating Systems Ltd. shareholders have approved an all-stock merger of equals with Akzo Nobel N.V. during a special general meeting on August 5, 2026. The Merger Proposal received strong support, with approximately 83.45% of entitled shares voting in favor. The merger is now …
Equitable Holdings (EQH) reported Q2 2026 adjusted EPS of $1.75, exceeding analyst estimates of $1.67, while revenue of $1.66 billion fell significantly short of the $3.85 billion forecast. Despite the revenue miss, management highlighted strong growth in retirement, wealth management, and asset management, alongside …
AkzoNobel shareholders have overwhelmingly approved all resolutions related to its proposed all-share merger with Axalta Coating Systems Ltd. This approval, mirrored by Axalta's shareholders, marks a significant step towards combining the two businesses. The merger is expected to finalize by the end of 2026 …
Axalta Coating Systems (AXTA) stock recently hit a 52-week high of $37.87, reflecting a significant 32.74% increase over the past year and 16.4% year-to-date. This surge follows strong second-quarter 2026 results, where the company surpassed Wall Street expectations with adjusted earnings of $0.72 per …
Equitable Holdings, Inc. (EQH) reported strong financial results for the second quarter, with adjusted earnings per share reaching $1.70. This performance exceeded the FactSet estimate of $1.65 per share.
Equitable Holdings, Inc. (EQH) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.1 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …
(RTTNews) - Equitable Holdings, Inc. (EQH) on Tuesday, reported a wider second-quarter loss but returned to profitability in the first half of 2026, as revenue declined from the prior year. For the second quarter, revenue decreased to $1.66 billion from $2.36 billion a year …
* Equitable Holdings press release [https://seekingalpha.com/pr/20606961-equitable-holdings-reports-second-quarter-2026-results] (EQH [https://seekingalpha.com/symbol/EQH]): Q2 Non-GAAP EPS of $1.70 beats by $0.06. * Revenue of $1.66B (-29.7% Y/Y) misses by $2.18B. * Share 0.52% MORE ON EQUITABLE HOLDINGS * Equitable Holdings Is A Hold, Expecting Successful Integration With Corebridge After …
Search by ticker symbol or company name and select a result to open its chart.